| Study | Sample size (MDD vs. HC) | Age (MDD vs. HC) | Sex (MDD vs. HC) | Drug status | Diagnosis | Depression severity mean (scale type) | Anxiety symptom severity mean (scale type) | Anxiety comorbidity | Atrophy | Hypertrophy | Coordinate system |
| Wagner et al., [45] | 15 vs. 16 | 41.4 vs. 38.8 | 15f vs. 16f | Drug-free | DSM-IV | 23.5 (HAMD), 28.1 (BDI) | NA | No | Yes | No | Talairach | Leung et al., [46] | 17 vs. 17 | 45.5 vs. 45.8 | 17f vs. 17f | Medicated | ICD-10 | 29.7 (BDI) | NA | No | Yes | Yes | Talairach | Mak et al., [47] | 17 vs. 17 | 45.5 vs. 45.8 | 17f vs. 17f | Medicated | ICD-10 | 29.7 (BDI) | NA | No | Yes | No | MNI | Zou et al., [48] | 23 vs. 23 | 31.1 vs. 36.6 | 13f/10m vs. 13f/10m | Drug-naïve | DSM-IV | 24.4 (HAMD) | NA | No | Yes | No | Talairach | Cheng et al., [49] | 68 vs. 68 | 29.91 vs. 29.91 | 47f/21m vs. 47f/21m | Drug-naïve | DSM-IV | 22.32 (HAMD) | 16.65 (HAMA) | No | Yes | No | MNI | Hwang et al., [50] | 70 vs. 26 | 79.4 vs. 79.5 | 70m vs. 26m | NA | DSM-IV | 29.1 (HAMD) | NA | No | Yes | Yes | Talairach | Scheuerecker et al., [51] | 13 vs. 15 | 37.9 vs. 35.5 | 3f/10m vs. 5f/10m | Drug-free | DSM-IV | 20.5 (HAMD) | NA | No | Yes | Yes | MNI | Amico et al., [52] | 33 vs. 30 | 32 vs. 30.7 | 14f/19m vs. 13f/17m | Medicated | NA | 23 (HAMD) | NA | No | No | Yes | MNI | Salvadore et al., [53] | 58 vs. 107 | 38.8 vs. 36.2 | 37f/21m vs. 60f/47m | Drug-free | DSM-IV | 26 (MADRS) | NA | No | Yes | No | Talairach | Ma et al., [54] | 17 vs. 17 | 26.71 vs. 24.24 | 7f/10m vs. 7f/10m | Drug-naïve | DSM-IV | 25.58 (HAMD) | NA | No | Yes | No | MNI | Wang et al., [55] | 18 vs. 18 | 34 vs. 35 | 9f/9m vs. 9f/9m | Drug-naïve | DSM-IV | 25 (HAMD) | 17 (HAMA) | No | Yes | No | MNI | Grieve et al., [56] | 102 vs. 34 | 31.5 vs. 33.8 | 54f/48m vs. 16f/18m | Drug-free | DSM-IV | 21 (HAMD) | NA | No | Yes | No | MNI | Chaney et al., [57] | 37 vs. 46 | 39.75 vs. 40.25 | 21f/16m vs. 28f/18m | Medicated | DSM-IV | 28.6 (HAMD), 34.1 (BDI) | NA | No | Yes | Yes | MNI | Guo et al., [58] | 44 vs. 44 | 27.52 vs. 29.39 | 22f/22m vs. 24f/20m | Drug-naïve | DSM-IV | 25.18 (HAMD) | NA | No | Yes | No | MNI | Jung et al., [59] | 24 vs. 29 | 43 vs. 43.6 | 17f/7m vs. 21f/8m | Medicated | DSM-IV | 20.9 (HAMD) | NA | No | Yes | No | MNI | Kong et al., [60] | 28 vs. 28 | 34.42 vs. 32.07 | 17f/11m vs. 14f/14m | Drug-naïve | DSM-IV | 21.65 (HAMD) | NA | No | Yes | Yes | MNI | Lai et al., [61] | 38 vs. 27 | 36.57 vs. 38.29 | 20f/18m vs. 15f/12m | Drug-naïve | DSM-IV | 22.26 (HAMD) | 2.36 (HAMA) | No | Yes | No | MNI | Modinos et al., [62] | 23 vs. 46 | 44.6 vs. 25.3 | 20f/3m vs. 14f/32m | NA | DSM-IV | NA | NA | No | Yes | No | MNI | Nakano et al., [63] | 36 vs. 54 | 49 vs. 45.4 | 22f/14m vs. 27f/27m | Medicated | DSM-IV-TR | 15.4 (HAMD) | NA | No | Yes | No | MNI | Peng et al., [44] | 20 vs. 28 | 27.75 vs. 28.61 | 13f/7m vs. 13f/15m | Medicated | DSM-IV | 25.95 (HAMD), 55.05 (SDS) | NA | No | Yes | Yes | MNI | 18 vs. 28 | 31.06 vs. 28.61 | 12f/6m vs. 13f/15m | Medicated | DSM-IV | 24.06 (HAMD), 56.94 (SDS) | NA | No | Yes | No | MNI | Qi et al., [64] | 18 vs. 28 | 31.06 vs. 28.61 | 11f/7m vs. 13f/15m | Drug-free | DSM-IV | 22.28 (HAMD), 51.67 (SDS) | 8.11 (HAMA), 27.67 (SAS) | No | Yes | No | MNI | Qiu et al., [65] | 46 vs. 46 | 34.9 vs. 35.4 | 33f/13m vs. 33f/13m | Drug-naïve | DSM-IV | 23.3 (HAMD) | NA | No | No | Yes | MNI | Cai et al., [66] | 23 vs. 23 | 30 vs. 28.2 | 10f/13m vs. 10f/13m | Medicated | DSM-IV | 29.7 (HAMD) | 9.22 (HAMA) | No | Yes | No | MNI | Dannlowski et al., [67] | 171 vs. 512 | 38.65 vs. 33.5 | 105f/66m vs. 289f/223m | Medicated | DSM-IV | 23.6 (BDI) | 59.35 (STAI-trait) | No | Yes | No | MNI | Fang et al., [68] | 20 vs. 18 | 59.2 vs. 59.1 | 8f/12m vs. 8f/10m | Medicated | DSM-IV | 26.6 (HAMD) | NA | No | Yes | No | MNI | Lai et al., [69] | 53 vs. 54 | 40.07 vs. 40.38 | 28f/25m vs. 29f/25m | Drug-naïve | DSM-IV | 22.43 (HAMD) | 2.20 (HAMA) | No | Yes | No | Talairach | Vasic et al., [70] | 43 vs. 29 | 37.1 vs. 34.5 | 26f/17m vs. 18f/11m | Medicated | DSM-IV | 20.09 (HAMD), 29 (BDI) | NA | No | Yes | No | MNI | Watanabe et al., [71] | 29 vs. 45 | 41.05 vs. 41.4 | 13f/16m vs. 12f/33m | Drug-free | DSM-IV-TR | 21.05 (HAMD) | NA | No | Yes | No | Talairach | Yang et al., (a) [72] | 50 vs. 50 | 31.12 vs. 31.30 | 31f/19m vs. 31f/19m | Drug-free | DSM-IV | 23.10 (HAMD) | 16.12 (HAMA) | No | Yes | Yes | MNI | Yang et al., (b) [73] | 51 vs. 51 | 30.98 vs. 31.14 | 31f/20m vs. 31f/20m | Drug-free | DSM-IV | 22.90 (HAMD) | 16.18 (HAMA) | No | Yes | Yes | MNI | Chen et al., [74] | 27 vs. 28 | 33 vs. 33 | 14f/13m vs. 14f/14m | Drug-naïve | DSM-IV | 22 (HAMD) | NA | No | No | Yes | MNI | Opel et al., [75] | 20 vs. 20 | 37.9 vs. 36.3 | 10f/10m vs. 10f/10m | Medicated | DSM-IV | 22.2 (HAMD), 45.3 (BDI) | NA | No | Yes | No | MNI | Qiu et al., [76] | 12 vs. 15 | 34.4 vs. 33.7 | 8f/4m vs. 10f/5m | Drug-free | DSM-IV | 35.9 (HAMD) | NA | No | Yes | No | MNI | Shen et al., [77] | 147 vs. 130 | 30.58 vs. 30.09 | 97f/50m vs. 81f/49m | Drug-naïve | DSM-IV | 23.83 (HAMD) | NA | No | Yes | Yes | MNI | Wang et al., [78] | 25 vs. 35 | 32.11 vs. 33.28 | 11f/14m vs. 16f/19m | Medicated | DSM-IV | 29.32 (HAMD) | 5.32 (HAMA) | No | Yes | No | MNI | Igata et al., [79] | 27 vs. 44 | 45.8 vs. 41.2 | 12f/15m vs. 12f/32m | Drug-naïve | DSM-IV-TR | 21.8 (HAMD) | NA | No | Yes | No | MNI | Yang et al., [80] | 82 vs. 82 | 28.85 vs. 27.72 | 53f/29m vs. 53f/29m | Drug-free | DSM-IV-TR | 23.1 (HAMD) | NA | No | Yes | No | MNI | Zhao et al., [81] | 37 vs. 41 | 26.7 vs. 27.1 | 12f/25m vs. 15f/26m | Drug-naïve | DSM-IV | 25 (HAMD) | 28.1 (HAMA) | No | Yes | Yes | MNI | Zhuo et al., [82] | 45 vs. 48 | 38.8 vs. 38.6 | 26f/19m vs. 27f/21m | Medicated | DSM-IV | 27.8 (HAMD) | NA | No | Yes | No | MNI | Chang et al., [83] | 108 vs. 156 | 20.61 vs. 22.25 | 70f/38m vs. 93f/63m | Medicated | DSM-IV | 20.15 (HAMD) | 14.94 (HAMA) | No | Yes | No | MNI | Chen et al., [84] | 36 vs. 47 | 30.7 vs. 29.7 | 16f/20m vs. 25f/22m | Drug-free | DSM-IV | 28 (HAMD) | NA | No | Yes | Yes | MNI | Lu et al., [85] | 76 vs. 86 | 33.4 vs. 34.65 | 44f/32m vs. 43f/43m | Drug-free | DSM-IV | 33.3 (HAMD) | NA | No | Yes | Yes | MNI | Zaremba et al., [86] | 37 vs. 54 | 37 vs. 37.5 | 19f/18m vs. 24f/30m | Medicated | DSM-IV | 22.9 (HAMD) | NA | No | Yes | No | MNI | Zhou et al., [87] | 114 vs. 111 | 28.17 vs. 27.63 | 54f/60m vs. 58f/53m | Drug-free | DSM-IV-TR | No less than 17 (HAMD) | NA | No | Yes | No | MNI | Gong et al., [88] | 92 vs. 201 | 34.96 vs. 29.61 | 49f/43m vs. 123f/78m | Drug-naïve | DSM-IV | 23.06 (HAMD) | NA | No | No | Yes | MNI | Hellewell et al., [89] | 98 vs. 66 | 33.3 vs. 30.09 | 45f/53m vs. 33f/33m | Drug-free | DSM-IV | 21.1 (HAMD) | NA | No | Yes | No | MNI | 131 vs. 66 | 33.2 vs. 30.09 | 77f/54m vs. 33f/33m | Drug-free | DSM-IV | 21.9 (HAMD) | NA | No | Yes | No | MNI | Kandilarova et al., [90] | 39 vs. 42 | 47.7 vs. 42.6 | 29f/10m vs. 29f/13m | Medicated | DSM-IV-TR | 29.1 (MADRS) | NA | No | Yes | No | MNI | Li et al., [91] | 56 vs. 56 | 35.1 vs. 30.7 | 36f/20m vs. 23f/33m | Drug-naïve | DSM-IV-TR | 25.1 (HAMD) | NA | No | Yes | Yes | MNI | Liu et al., [92] | 24 vs. 30 | 34.79 vs. 33.43 | 15f/9m vs. 14f/16m | Drug-naïve | DSM-5 | 25.5 (HAMD) | NA | No | Yes | No | MNI | 21 vs. 30 | 34.14 vs. 33.43 | 11f/10m vs. 14f/16m | Drug-naïve | DSM-5 | 24.48 (HAMD) | NA | No | Yes | Yes | MNI | Peng et al., [93] | 104 vs. 160 | 33 vs. 32 | 62f/42m vs. 93f/67m | NA | DSM-IV | 28 (HAMD) | 28 (HAMA) | No | Yes | Yes | MNI | 57 vs. 160 | 31 vs. 32 | 36f/21m vs. 93f/67m | NA | DSM-IV | 24 (HAMD) | 17 (HAMA) | No | No | Yes | MNI | Straub et al., [94] | 42 vs. 43 | NA vs. 17.62 | NA vs. 38f/5m | Medicated | DSM-IV | NA | NA | No | No | Yes | MNI | Chen et al., [95] | 22 vs. 22 | 28.7 vs. 27.4 | 18f/4m vs. 18f/4m | Medicated | DSM-5 | 24.5 (MADRS) | NA | No | Yes | No | MNI | Liu et al., [96] | 22 vs. 27 | 32.09 vs. 32.44 | 12f/10m vs. 14f/13m | Drug-naïve | DSM-5 | 27.03 (HAMD) | NA | No | Yes | Yes | MNI | 36 vs. 27 | 35.75 vs. 32.44 | 21f/15m vs. 14f/13m | Drug-naïve | DSM-5 | 24.45 (HAMD) | NA | No | Yes | No | MNI | Meng et al., [97] | 159 vs. 53 | 33.71 vs. 35.64 | 83f/76m vs. 25f/28m | Drug-naïve | DSM-5 | 23.6 (HAMD) | NA | No | Yes | No | MNI | Nan et al., [98] | 166 vs. 166 | 33.69 vs. 34.64 | 115f/51m vs. 115f/51m | Drug-naïve | DSM-IV | 23.75 (HAMD) | NA | No | Yes | Yes | MNI | Yang et al., [99] | 68 vs. 103 | 32.8 vs. 32.1 | 54f/14m vs. 67f/36m | Drug-free | DSM-IV | 24 (HAMD) | NA | No | Yes | Yes | MNI | 119 vs. 103 | 34.6 vs. 32.1 | 65f/54m vs. 67f/36m | Drug-free | DSM-IV | 21.9 (HAMD) | NA | No | Yes | No | MNI | Zhang et al., [100] | 53 vs. 50 | 38.1 vs. 34.2 | 34f/19m vs. 34f/16m | Drug-naïve | ICD-10 | 19.83 (HAMD) | NA | No | Yes | No | MNI | Jiang et al., [101] | 20 vs. 30 | 27.4 vs. 26.47 | 12f/8m vs. 15f/15m | Drug-naïve | DSM-IV | 21.25 (HAMD) | 18.81 (HAMA) | No | Yes | No | MNI | Liu et al., [102] | 149 vs. 446 | 30.76 vs. 33.15 | 93f/56m vs. 252f/194m | NA | DSM-IV | 19.28 (HAMD) | NA | No | Yes | Yes | MNI | 335 vs. 446 | 34.35 vs. 33.15 | 219f/116m vs. 252f/194m | NA | DSM-IV | 23.68 (HAMD) | NA | No | No | Yes | MNI | Ma et al., [103] | 52 vs. 65 | 24.98 vs. 25.25 | 34f/18m vs. 32f/33m | Medicated | DSM-IV-TR | NA | NA | No | Yes | No | MNI | Takamiya et al., [104] | 48 vs. 52 | 74.1 vs. 72.4 | 33f/15m vs. 37f/15m | Medicated | DSM-IV-TR | 23.1 (Geriatric Depression Scale) | NA | No | Yes | No | MNI | Zhang et al., [105] | 20 vs. 20 | 28 vs. 31.7 | 13f/7m vs. 10f/10m | Drug-free | DSM-IV | 26.5 (HAMD) | NA | No | Yes | Yes | MNI | Zhou et al., [106] | 109 vs. 163 | 27.43 vs. 28.1 | 72f/37m vs. 96f/67m | Drug-free | DSM-IV-TR | 20.4 (HAMD) | 16.22 (HAMA) | No | Yes | No | MNI | Kang et al., [107] | 77 vs. 111 | 22.09 vs. 26.01 | 62f/15m vs. 87f/24m | Medicated | DSM-5 | NA | NA | No | Yes | No | MNI | Li et al., [108] | 30 vs. 25 | 14.6 vs. 15.48 | 22f/8m vs. 19f/6m | Drug-free | DSM-IV | 29.03 (HAMD) | NA | No | Yes | No | MNI | Liu et al., [109] | 64 vs. 61 | 28.47 vs. 30.49 | 37f/27m vs. 25f/36m | Drug-free | DSM-IV | 27.78 (HAMD) | NA | No | Yes | No | MNI | Lu et al.,[110] | 108 vs. 99 | 33.56 vs. 35.93 | 63f/45m vs. 50f/49m | Medicated | DSM-IV-TR | 27.07 (HAMD) | NA | No | Yes | No | MNI | Lu et al., [111] | 22 vs. 20 | 28.6 vs. 27.7 | 17f/5m vs. 10f/10m | Drug-free | DSM-IV-TR | 25.2 (HAMD) | NA | No | Yes | No | MNI | Sun et al., [112] | 342 vs. 510 | 35.98 vs. 33.24 | 221f/121m vs. 291f/219m | NA | DSM-IV or ICD-10 | 24.36 (HAMD) | NA | No | Yes | Yes | MNI | 208 vs. 510 | 31.24 vs. 33.24 | 131f/77m vs. 291f/219m | NA | DSM-IV or ICD-10 | 16.83 (HAMD) | NA | No | Yes | No | MNI | Wang et al., [113] | 1082 vs. 990 | 37.23 vs. 37.45 | 678f/404m vs. 580f/410m | Medicated | DSM-5 or ICD-10 | 20.75 (HAMD) | 19.09 (HAMA) | No | Yes | No | MNI | Yang et al., [114] | 85 vs. 95 | 32.44 vs. 30.21 | 51f/34m vs. 48f/47m | Medicated | DSM-IV | 18.6 (BDI) | 42.83 (BAI) | No | Yes | No | MNI | Yu et al., [115] | 35 vs. 53 | 30.26 vs. 27.47 | 20f/15m vs. 31f/22m | Medicated | DSM-IV | 21.83 (HAMD) | NA | No | Yes | No | MNI | Zhang et al., [116] | 26 vs. 35 | 26.42 vs. 25.45 | 13f/13m vs. 18f/17m | Drug-free | DSM-IV | 21.12 (HAMD) | NA | No | No | Yes | MNI | Lai et al., [117] | 16 vs. 15 | 37.91 vs. 34.3 | 11f/5m vs. 11f/4m | Drug-naïve | DSM-IV | 35.91 (HAMD), 26.09 (QIDS-SR16) | 33 (HAMA), 18.55 (PDSS) | Yes (16 patients with comorbid panic disorder) | Yes | No | MNI | Qi et al., [64] | 20 vs. 28 | 28.65 vs. 28.61 | 9f/11m vs. 13f/15m | Drug-free | DSM-IV | 20.25 (HAMD), 51.67 (SDS) | 16.80 (HAMA), 47.10 (SAS) | Yes (patients with comorbid anxiety disorders) | No | Yes | MNI | Stratmann et al., [118] | 132 vs. 132 | 37.86 vs. 37.82 | 76f/56m vs. 74f/58m | Medicated | DSM-IV | 20.15 (HAMD), 21.95 (BDI) | NA | Yes (41 patients with comorbid anxiety disorders) | Yes | No | MNI | Harada et al., [119] | 45 vs. 61 | 60.2 vs. 62.9 | 26f/19m vs. 44f/17m | Medicated | DSM-IV-TR | 24.8 (BDI), 17.3 (SIGH-D) | NA | Yes (1 patient with comorbid panic disorder; 1 patient with comorbid social anxiety disorder) | Yes | No | MNI | Yang et al., [120] | 35 vs. 23 | 44.54 vs. 39.09 | 35f vs. 23f | Drug-free | DSM-IV | 28.29 (HAMD) | 20.17 (HAMA) | Yes (patients with high rates of comorbid anxiety disorders) | Yes | No | MNI | Lu et al., [121] | 30 vs. 48 | 23.95 vs. 21.5 | 13f/17m vs. 30f/18m | Drug-free | DSM-IV | 30.1 (HAMD), 71.5 (SDS) | NA | Yes (patients with comorbid anxiety disorders) | Yes | Yes | MNI | Zhang et al., [122] | 30 vs. 63 | 25 vs. 23 | 21f/9m vs. 39f/24m | Drug-naïve | DSM-5 | 26.5 (HAMD) | 28 (HAMA) | Yes (patients with comorbid anxiety disorders) | Yes | No | MNI |
|
|